Clinical Trials
Epcoritamab + Rituximab and Lenalidomide vs. Chemoimmunotherapy in Previously Untreated Follicular Lymphoma
Disease Type: Lymphoma
A Phase 3, Multicenter, Randomized, Open-Label Trial to Evaluate the Safety and Efficacy of Epcoritamab + Rituximab and Lenalidomide (R2) compared to Chemoimmunotherapy in Previously Untreated Follicular Lymphoma
Locations
Roanoke